Author: PharmaTimes

Clean Air Advantage

Compressed air is among the largest energy expenses in pharmaceutical manufacturing and must remain entirely contamination-free.

Ondine Biomedical has announced the North American phase 3 study has reached more than 93% enrolment, bringing the company closer to FDA submission.

IsomAb has appointed Dr Philip Brainin as CEO and member of the Board of Directors.

Re:Cognition Health and Cera collaborate to expand access to Alzheimer’s and neurodegenerative clinical trials

Recognising the achievements of this year’s standout healthcare collaborations

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN